RVV up nearly 50% on minor PR..imagine THRM on approval Today Revive Therapeutics jumped nearly 50% merely on a report that its Covid-19 treatment Bucillamine has had some endpoints agreed to by the FDA in a phase 3 trial.
imagine how far up Therma could go with a real substantive press release like "HC approved" etc.